Jackson WT - Search Results

1

Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.

Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL Jr, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T Jr, Snyder DW, Pechous PA, Spaethe SM, Roman CR, Fleisch JH. Jackson WT, et al. J Pharmacol Exp Ther. 1999 Jan;288(1):286-94. J Pharmacol Exp Ther. 1999. PMID: 9862783

2

Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.

Herron DK, Goodson T, Bollinger NG, Swanson-Bean D, Wright IG, Staten GS, Thompson AR, Froelich LL, Jackson WT. Herron DK, et al. Among authors: jackson wt. J Med Chem. 1992 May 15;35(10):1818-28. doi: 10.1021/jm00088a018. J Med Chem. 1992. PMID: 1316967

3

Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.

Jackson WT, Boyd RJ, Froelich LL, Mallett BE, Gapinski DM. Jackson WT, et al. J Pharmacol Exp Ther. 1992 Dec;263(3):1009-14. J Pharmacol Exp Ther. 1992. PMID: 1335049

4

Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus.

Gapinski DM, Mallett BE, Froelich LL, Jackson WT. Gapinski DM, et al. Among authors: jackson wt. J Med Chem. 1990 Oct;33(10):2798-807. doi: 10.1021/jm00172a019. J Med Chem. 1990. PMID: 2170647

5

Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain.

Gapinski DM, Mallett BE, Froelich LL, Jackson WT. Gapinski DM, et al. Among authors: jackson wt. J Med Chem. 1990 Oct;33(10):2807-13. doi: 10.1021/jm00172a020. J Med Chem. 1990. PMID: 2170648

6

Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.

Sawyer JS, Bach NJ, Baker SR, Baldwin RF, Borromeo PS, Cockerham SL, Fleisch JH, Floreancig P, Froelich LL, Jackson WT, et al. Sawyer JS, et al. Among authors: jackson wt. J Med Chem. 1995 Oct 27;38(22):4411-32. doi: 10.1021/jm00022a006. J Med Chem. 1995. PMID: 7473568

7

o-phenylphenols: potent and orally active leukotriene B4 receptor antagonists.

Sofia MJ, Floreancig P, Bach NJ, Baker SR, Cockerham SL, Fleisch JH, Froelich LL, Jackson WT, Marder P, Roman CR, et al. Sofia MJ, et al. Among authors: jackson wt. J Med Chem. 1993 Nov 26;36(24):3978-81. doi: 10.1021/jm00076a029. J Med Chem. 1993. PMID: 7902871 No abstract available.

8

Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.

Harper RW, Jackson WT, Froelich LL, Boyd RJ, Aldridge TE, Herron DK. Harper RW, et al. Among authors: jackson wt. J Med Chem. 1994 Jul 22;37(15):2411-20. doi: 10.1021/jm00041a021. J Med Chem. 1994. PMID: 8057289

9

Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.

Jackson WT, Boyd RJ, Froelich LL, Gapinski DM, Mallett BE, Sawyer JS. Jackson WT, et al. J Med Chem. 1993 Jun 11;36(12):1726-34. doi: 10.1021/jm00064a006. J Med Chem. 1993. PMID: 8389876

10

Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.

Fleisch JH, Armstrong CT, Roman CR, Mihelich ED, Spaethe SM, Jackson WT, Bobbitt JL, Draheim S, Bach NJ, Dillard RD, Martinelli M, Fouts R, Snyder DW. Fleisch JH, et al. Among authors: jackson wt. J Pharmacol Exp Ther. 1996 Jul;278(1):252-7. J Pharmacol Exp Ther. 1996. PMID: 8764358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters